Uromodulin Antibody (3F10)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This gene encodes uromodulin, the most abundant protein in normal urine. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. Uromodulin may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of uromodulin in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the autosomal dominant renal disorders medullary cystic kidney disease-2 (MCKD2) and familial juvenile hyperuricemic nephropathy (FJHN). These disorders are characterized by juvenile onset of hyperuricemia, gout, and progressive renal failure. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same isoform. [provided by RefSeq]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 3 of 3.

Publications using H00007369-M03	Applications	Species
Yuchao C, Qingfu Z, Liming C et al. Exosome detection via the ultrafast-isolation system: EXODUS. Nat Methods. 2021-01-11 [PMID: 33432243]
Jou YC, Tsai YS, Fang CY et al. Mass spectrometric study of stone matrix proteins of human bladder stones. Urology. 2013-08-01 [PMID: 23896093]
Jou YC, Fang CY, Chen SY et al. Proteomic Study of Renal Uric Acid Stone. Urology. 2012-04-17 [PMID: 22516363]

Array H00007369-M03

• Uromodulin Antibodies
• Uromodulin ELISA Kits
• Uromodulin Lysates
• Uromodulin Proteins
• Uromodulin ELISA